ELV - Elevance Health Inc Stock Analysis
Elevance Health Inc (ELV) is a publicly traded company listed on the NYSE. It operates in the Healthcare Plans industry, part of the broader Healthcare sector. The company has a market capitalization of 72.41B, generates annual revenue of 194.82B, and reports net income of 5.53B. As of the latest data, the stock is trading at 325.83 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (2.06%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.76), indicating current market sentiment. Institutional ownership is reported at 91.46%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -21.09%, trading within a 52-week range of 273.71 - 458.75.
ELV - Elevance Health Inc
325.83
Analyst Consensus
Hold 3.76
ELV – Analyst Rating Summary
- Strong Buy: 5
- Buy: 12
- Hold: 12
- Sell: 0
- Strong Sell: 0
- Total Analysts: 29
| Index: | S&P 500 | P/E: | 13.33 | EPS (ttm): | 24.45 | Insider Own: | 0.26% | Shs Outstand: | 222.04M | Perf Week: | 2.53% |
| Market Cap: | 72.41B | Forward P/E: | 11.97 | EPS next Y: | 27.23 | Insider Trans: | 1.71% | Shs Float: | 221.66M | Perf Month: | -6.42% |
| Income(ttm): | 5.53B | PEG: | - | EPS next Q: | 3.17 | Inst Own: | 91.46% | Short Float: | 1.57% | Perf Quarter: | 5.34% |
| Revenue(ttm): | 194.82B | P/S: | 0.37 | EPS this Y: | -9.21% | Inst Trans: | 1.65% | Short Ratio: | 1.81 | Perf Half Y: | -19.21% |
| Book/sh: | 197.95 | P/B: | 1.65 | EPS next Y: | -9.23% | ROA: | 4.62% | Short Interest: | 3.48M | Perf Year: | -21.09% |
| Cash/sh: | - | P/C: | - | EPS next 5Y: | -1.51% | ROE: | 12.61% | 52W Range: | 273.71 - 458.75 | Perf YTD: | -11.68% |
| Dividend Est.: | 6.72 (2.06%) | P/FCF: | 19.22 | EPS past 3/5Y: | 1.26% 6.81% | ROIC: | 7.36% | 52W High: | 458.75 -28.97% | Beta: | 0.52 |
| Dividend TTM: | 6.76 (2.07%) | Quick Ratio: | - | Sales past 3/5Y: | 8.44% 11.15% | Gross Margin: | - | 52W Low: | 273.71 19.04% | Perf 5Y: | 1.06% |
| Dividend Ex-Date: | Dec 05, 2025 | Current Ratio: | 1.56 | EPS Y/Y TTM: | -11.11% | Oper. Margin: | 4.35% | RSI (14): | 48.64 | Volatility: | 4.33% 3.18% |
| Employees: | 104200 | Debt/Eq: | 0.73 | Sales Y/Y TTM: | 11.96% | Profit Margin: | 2.84% | Recom: | 2.04 | Target Price: | 377.11 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.71 | EPS Q/Q: | 21.95% | Payout: | 25.39% | Rel Volume: | 0.72 | Prev Close: | 328.28 |
| Sales Surprise: | 1.39% | EPS Surprise: | 22.24% | Sales Q/Q: | 12.33% | Earnings: | Oct 21 BMO | Avg Volume: | 1.93M | Price: | 325.83 |
| SMA20: | -0.90% | SMA50: | -1.18% | SMA200: | -10.30% | Undervalued: 15.74% | Volume: | 1,392,767 | Change: | -0.75% | |
Graham Classic formula value: 120.31
(P/E=8 * 1g) Min value: 142.49
(current P/E * 2g) Max value: 226.36
Average value: 163.05
About Elevance Health Inc
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.